WHO chooses M'sia to run trials on new drug to fight Covid-19


PETALING JAYA: Malaysia has been chosen by the World Health Organisation (WHO) as one of the countries to run trials on the effectiveness of a drug called Remdesevir to treat Covid-19 patients, says the National Security Council (NSC).

NSC said that Malaysia was chosen due to the ability of the Health ministry to undertake the research.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Man arrested, yaba pills worth over RM12,000 seized
Skywatchers out in force
Photo gallery: KKB by-election Nomination Day
KKB by-election: Live updates
Fahmi: No MPs from state objected when Territorial Sea Act passed in 2012
Tax returns submission deadline extended to May 15
Battle of competing narratives
Swift medical aid just a QR code away for haj pilgrims
AI content must not cross the line
Springtime celebrations

Others Also Read